I used Refmac 5.3.0037 to refine a structure. Is there a problem with this 
version too?
Thank you in advance,
Madhavi


-----Original Message-----
From: CCP4 bulletin board [mailto:[EMAIL PROTECTED] On Behalf Of Ian Tickle
Sent: Wednesday, September 19, 2007 8:21 AM
To: CCP4BB@JISCMAIL.AC.UK
Subject: Re: [ccp4bb] anisotropic scaling in refmac versions

I think this isn't a problem in the latest version of Refmac (0040 I think), so 
try downloading it from the York site.

-- Ian 

> -----Original Message-----
> From: [EMAIL PROTECTED] 
> [mailto:[EMAIL PROTECTED] On Behalf Of Alejandro Buschiazzo
> Sent: 19 September 2007 13:20
> To: Lari Lehtio
> Cc: CCP4BB@JISCMAIL.AC.UK
> Subject: Re: [ccp4bb] anisotropic scaling in refmac versions
> 
> Hello,
> I wonder if there was any direct answer to the question that 
> Lari made a 
> couple of days ago.
> Sorry if I missed it, but I believe there wasn't any response to the 
> ccp4bb...
> 
> thanks
> 
> Alejandro
> 
> 
> Lari Lehtio wrote:
> > Dear All,   
> >   
> > I just came back from the beam line and started to continue 
> my work on a structure that I solved  
> > while collecting other data. I noticed that my R-factors 
> were a lot higher at home lab although  
> > I was using the exact same input files.   
> >   
> > I then noticed that the version was different:   
> >   
> > The one giving lower R-factors was   
> > Refmac_5.2.0019    version 5.2.0019  : 06/09/05  
> >   
> > And the one giving higher:  
> > Refmac_5.3.0032    version 5.3.0032  : 02/16/06  
> >   
> > I happened to have the older version also in my home pc, so 
> I tried again and indeed, 5.2.0019  
> > gives lower R-factors.   
> >   
> > The input command is identical, but when I "diffed" the 
> pdb-files, I noticed that anisotropic 
> > scale is missing in the newer files. Did I make a mistake? 
> How can I turn it back on.  
> >  
> > Below is the diff output and the command used for refmac. 
> >  
> > Thank you in advance, 
> >  
> > ~L~ 
> >  
> > < REMARK   3   PROGRAM     : REFMAC 5.2.0019 
> >   
> >> REMARK   3   PROGRAM     : REFMAC 5.3.0032 
> >>     
> > < REMARK   3   R VALUE     (WORKING + TEST SET) : 0.21101 
> > < REMARK   3   R VALUE            (WORKING SET) :  0.20867 
> > < REMARK   3   FREE R VALUE                     :  0.25559 
> >   
> >> REMARK   3   R VALUE     (WORKING + TEST SET) : 0.23077 
> >> REMARK   3   R VALUE            (WORKING SET) :  0.22807 
> >> REMARK   3   FREE R VALUE                     :  0.28228 
> >>     
> > < REMARK   3   BIN R VALUE           (WORKING SET) :    0.240 
> >   
> >> REMARK   3   BIN R VALUE           (WORKING SET) :    0.262 
> >>     
> > < REMARK   3   BIN FREE R VALUE                    :    0.288 
> >   
> >> REMARK   3   BIN FREE R VALUE                    :    0.343 
> >>     
> > < REMARK   3   MEAN B VALUE      (OVERALL, A**2) :  25.271 
> >   
> >> REMARK   3   MEAN B VALUE      (OVERALL, A**2) :  29.941 
> >>     
> > < REMARK   3    B11 (A**2) :     2.35 
> > < REMARK   3    B22 (A**2) :    -1.99 
> > < REMARK   3    B33 (A**2) :     0.32 
> >   
> >> REMARK   3    B11 (A**2) :     0.00 
> >> REMARK   3    B22 (A**2) :     0.00 
> >> REMARK   3    B33 (A**2) :     0.00 
> >>     
> > < REMARK   3    B13 (A**2) :     0.90 
> >   
> >> REMARK   3    B13 (A**2) :     0.00 
> >>     
> >  
> > 
> ______________________________________________________________
> _______________________ 
> > make check NONE 
> > make - 
> >     hydrogen YES - 
> >     hout NO - 
> >     peptide NO - 
> >     cispeptide YES - 
> >     ssbridge YES - 
> >     symmetry YES - 
> >     sugar YES - 
> >     connectivity NO - 
> >     link NO 
> > refi - 
> >     type REST - 
> >     resi MLKF - 
> >     meth CGMAT - 
> >     bref ISOT 
> > ncyc 10 
> > scal - 
> >     type SIMP - 
> >     reso 2.100 19.976 - 
> >     LSSC - 
> >     ANISO - 
> >     EXPE 
> > solvent YES - 
> >     VDWProb 1.4 - 
> >     IONProb 0.8 - 
> >     RSHRink 0.8 
> > weight - 
> >     MATRIX 0.1 
> > monitor MEDIUM - 
> >     torsion 10.0 - 
> >     distance 10.0 - 
> >     angle 10.0 - 
> >     plane 10.0 - 
> >     chiral 10.0 - 
> >     bfactor 10.0 - 
> >     bsphere 10.0 - 
> >     rbond 10.0 - 
> >     ncsr 10.0 
> > labin  FP=FP SIGFP=SIGFP - 
> >    FREE=FreeRflag 
> > labout  FC=FC FWT=FWT PHIC=PHIC PHWT=PHWT DELFWT=DELFWT 
> PHDELWT=PHDELWT FOM=FOM 
> > PNAME unknown 
> > DNAME unknown130907 
> > RSIZE 80 
> > END 
> >  
> > _______________________________________  
> >   
> >  Lari Lehtiƶ  
> >  Structural Genomics Consortium  
> >  Medical Biochemistry & Biophysics Dept.                     
> >  Karolinska Institute  
> >  Stockholm, Sweden  
> > _______________________________________  
> >   
> >
> >   
> 
> 
> -- 
> Alejandro Buschiazzo, PhD
> Research Scientist
> Laboratory of Structural Biology
> Pasteur Institute of Montevideo
> Mataojo 2020
> Montevideo 11400
> URUGUAY
> 
> Phone: +5982 5220910 int. 120
> Fax:   +5982 5224185
> 
> 


Disclaimer
This communication is confidential and may contain privileged information 
intended solely for the named addressee(s). It may not be used or disclosed 
except for the purpose for which it has been sent. If you are not the intended 
recipient you must not review, use, disclose, copy, distribute or take any 
action in reliance upon it. If you have received this communication in error, 
please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy 
all copies of the message and any attached documents. 
Astex Therapeutics Ltd monitors, controls and protects all its messaging 
traffic in compliance with its corporate email policy. The Company accepts no 
liability or responsibility for any onward transmission or use of emails and 
attachments having left the Astex Therapeutics domain.  Unless expressly 
stated, opinions in this message are those of the individual sender and not of 
Astex Therapeutics Ltd. The recipient should check this email and any 
attachments for the presence of computer viruses. Astex Therapeutics Ltd 
accepts no liability for damage caused by any virus transmitted by this email. 
E-mail is susceptible to data corruption, interception, unauthorized amendment, 
and tampering, Astex Therapeutics Ltd only send and receive e-mails on the 
basis that the Company is not liable for any such alteration or any 
consequences thereof.
Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, 
Cambridge CB4 0QA under number 3751674

Reply via email to